Home

helps physicians and healthcare professionals

Erectile Dysfunction

helps physicians and healthcare professionals

Doctor123.org

helps physicians and healthcare professionals

Methemoglobinemia, Pediatric


Basics


Description


  • Methemoglobin is dysfunctional hemoglobin in which the deoxygenated heme moiety has been oxidized from the ferrous (Fe2+) to the ferric (Fe3+) state.
  • Methemoglobinemia is an undue accumulation of methemoglobin within the blood.

Epidemiology


  • Toxic methemoglobinemia, resulting from exposure to oxidant chemicals or drugs, is the most common cause of methemoglobinemia among children older than 6 months of age.
  • Enteritis-associated methemoglobinemia is the most common cause among children younger than 6 months of age:
    • As many as 2/3 of infants with severe diarrhea have methemoglobinemia.

Pathophysiology


  • Hemoglobin in the allosteric configuration of methemoglobin cannot carry oxygen.
  • Methemoglobin increases the oxygen affinity of normal heme moieties in the blood and results in impaired oxygen delivery to tissues.
  • NADH-dependent cytochrome b5 methemoglobin reductase is the major source of physiologic reduction of methemoglobin.
  • A normally dormant NADPH-dependent methemoglobin reductase is the site of action for antidotal methylene blue therapy.

Etiology


  • Toxic methemoglobinemia
    • Dietary or environmental chemicals: chlorates, chromates, copper sulfate fungicides, naphthalene, nitrates, and nitrites
    • Industrial chemicals: aniline and other nitrogenated organic compounds
    • Drugs: amyl nitrite, benzocaine, dapsone, lidocaine, metoclopramide, nitric oxide, nitroprusside, phenazopyridine, prilocaine, many others
    • Methemoglobinemia is a common iatrogenic complication of drug therapy.
  • Enteritis-associated methemoglobinemia is multifactorial in origin:
    • Intestinal nitrate and nitric oxide promotes methemoglobin formation.
    • Innate enzymatic methemoglobin reduction systems may be underdeveloped during infancy.
    • Acidemia further inhibits enzymatic methemoglobin reduction systems.
    • Methemoglobinemia is also reported with nitrite-producing bacterial infections of the intestines or urinary tract.
  • Congenital methemoglobinemia (rare)
    • Hemoglobin M: Heterozygotes for autosomal dominant hemoglobin M will exhibit lifelong cyanosis.
    • NADH-dependent methemoglobin reductase deficiency: Homozygotes for this autosomal recessive enzyme will have lifelong cyanosis; heterozygotes may have increased susceptibility to oxidative hemoglobin injury.

Commonly Associated Conditions


  • Heinz body hemolytic anemia
    • Oxidant stress on the globin protein may cause hemolysis.
  • Sulfhemoglobinemia
    • Oxidant stress on the hemoglobin porphyrin ring may cause sulfhemoglobinemia.

Diagnosis


History


  • Age of onset
    • New onset of cyanosis in children older than 6 months of age is unlikely to be due to congenital or enteritis-associated methemoglobinemia.
  • Source of water
    • Well water may be contaminated with nitrates.
  • Drug or chemical exposure
    • May suggest a source of toxic methemoglobinemia
  • Diarrhea
    • May suggest enteritis-associated methemoglobinemia

Physical Exam


  • Cyanosis
    • Cyanosis becomes apparent in the presence of 1.5 g/dL of methemoglobin (in contrast to 4 " “5 g/dL of deoxyhemoglobin).
  • Heart murmur
    • May suggest right-to-left intracardiac shunting rather than methemoglobinemia
  • Abnormal lung auscultation:
    • May suggest cyanosis due to pulmonary disorder
  • Signs and symptoms
    • Malaise
    • Fatigue
    • Dyspnea
    • Tachycardia
    • Cyanosis

Diagnostic Tests & Interpretation


Lab
  • Oxygen saturation
    • Oxygen saturation measured by pulse oximetry is artificially low, but oxygen saturation calculated from arterial blood gas is normal (a "saturation gap " ).
  • Co-oximetry
    • Multiple-wavelength co-oximetry is the standard for quantifying methemoglobin in the blood.
  • Hemoglobin quantitation
    • The percent methemoglobin concentration must be considered in relation to the total hemoglobin.
    • Anemia may suggest concurrent hemolysis.
  • Serum bicarbonate
    • Metabolic acidosis is relatively mild in cases of <40% toxic methemoglobinemia.
    • Metabolic acidosis is typically profound in cases of enteritis-associated methemoglobinemia.
  • Glucose-6-phosphate dehydrogenase (G6PD) assay
    • G6PD deficiency does not predispose to methemoglobinemia and should not be routinely ordered.
  • Hemoglobin electrophoresis
    • Hemoglobin M is rare and does not respond to therapy.
    • This test should not be routinely ordered.

Diagnostic Procedures/Other
  • Pulse oximetry may be inaccurate in the setting of methemoglobinemia or methylene blue therapy.
  • Blood may have a "chocolate brown "  appearance despite exposure to air.

Differential Diagnosis


  • Environmental hypoxia
  • Cardiovascular disease
  • Pulmonary disease
  • Sulfhemoglobinemia
  • Factitious skin discoloration

Treatment


Medication


  • Consider administration of 1% methylene blue.
    • Dose: 1 " “2 mg/kg IV over 5 minutes, repeated as necessary (caution above 4 " “7 mg/kg total)
    • Indications: signs of tissue hypoxia, CNS depression, >30% methemoglobinemia
    • Contraindications (relative): known, severe G6PD deficiency
  • Methylene blue therapy may be ineffective if
    • Patient is G6PD deficient.
    • Ongoing drug or chemical absorption or biotransformation leads to continuing methemoglobin formation.
    • Sulfhemoglobin is present.
    • Hemoglobin M is present.
    • High doses of methylene blue add to, rather than ameliorate, the oxidant stress.

Additional Therapies


General Measures
  • Acquired methemoglobinemia
    • Administer 100% oxygen.
    • Decontaminate or remove from toxic source of oxidative stress.
    • Alleviate enteritis with IV fluids or elemental formulas.
    • Treat identified bacterial infections.
    • Exchange transfusion is a consideration of last resort.
  • Congenital methemoglobinemia
    • No beneficial therapy exists for hemoglobin M.
    • Oral methylene blue or ascorbic acid may provide alternative reduction pathways for patients with NADH-dependent reductase deficiencies.

Ongoing Care


Follow-up Recommendations


  • Toxic methemoglobinemia
    • Consider consultation with a medical toxicologist.
    • May require environmental investigation
  • Enteritis-associated methemoglobinemia
    • Careful formula rechallenge warranted if possibility exists for milk protein allergy or other dietary intolerance
  • Congenital methemoglobinemia
    • Consider consultation with a hematologist.

Prognosis


  • Toxic methemoglobinemia
    • Full recovery with recognition, removal of oxidant stress, and appropriate therapy
  • Enteritis-associated methemoglobinemia
    • Methemoglobinemia may be prolonged and relapsing until enteritis healed.
  • Congenital methemoglobinemia
    • Lifelong cyanosis expected

Complications


  • >10% methemoglobinemia
    • Cyanosis
  • >30% methemoglobinemia
    • Malaise, fatigue, dyspnea, tachycardia
  • >50% methemoglobinemia
    • Somnolence, tissue ischemia
  • 60% methemoglobinemia
    • Potential lethality

Additional Reading


  • Canning ‚  J, Levine ‚  M. Case files of the medical toxicology fellowship at Banner Good Samaritan Medical Center in Phoenix, AZ: methemoglobinemia following dapsone exposure. J Med Toxicol.  2011;7(2):139 " “146. ‚  [View Abstract]
  • Osterhoudt ‚  KC. Methemoglobinemia. In: Erickson ‚  TB, Ahrens ‚  WR, Aks ‚  SE, eds. Pediatric Toxicology. New York: McGraw Hill; 2005:492 " “500.
  • Skold ‚  A, Cosco ‚  DL, Klein ‚  R. Methemoglobinemia: pathogenesis, diagnosis, and management. South Med J.  2011;104(11):757 " “761. ‚  [View Abstract]

Codes


ICD09


  • 289.7 Methemoglobinemia

ICD10


  • D74.9 Methemoglobinemia, unspecified
  • D74.8 Other methemoglobinemias
  • D74.0 Congenital methemoglobinemia

SNOMED


  • 38959009 Methemoglobinemia (disorder)
  • 191390009 Drug-induced methemoglobinemia
  • 267550008 Congenital methemoglobinemia (disorder)

FAQ


  • Q: Can methemoglobinemia be diagnosed by the color of the blood?
  • A: The "chocolate brown "  blood of methemoglobinemia is most easily noted when compared to "control "  blood on a white filter paper background. In contrast to deoxygenated blood from patients with cardiopulmonary disease, methemoglobin-darkened blood does not redden on exposure to room air.
  • Q: Is methemoglobin responsible for the profound metabolic acidosis often found in diarrheal infants?
  • A: Benzocaine-induced methemoglobinemia rarely causes acidosis in infants. In contrast, infants with enteritis-associated methemoglobinemia often have a profound acidemia with a relatively narrow anion gap. Acidosis should be considered a contributing or coexisting factor, rather than a result, of methemoglobinemia among infants with diarrhea.
Copyright © 2016 - 2017
Doctor123.org | Disclaimer